Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
User-filled Paper Applicator for Tenofovir Gel
NCT02179138Phase 2Withdrawn
- Sponsor
- CONRAD
- Primary completion
- Mar 2015
- Modality
- Implantable Devices, Transdermal Patches, Hydrogel Systems
- Countries
- 1
01
Overview
A Phase 2 trial of tenofovir gel in human immunodeficiency virus infection (HIV), sponsored by CONRAD. Status: withdrawn.
02
Drugs
tenofovir gel
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02179138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02179138.